MHA 515 Week 6 Innovations in Health Care Example

Four Innovations, One Budget: Judging Blood Pressure Telemonitoring, Obesity Medicines, Ambient Scribes and Hospital Care at Home for a Tucson System

[Student Name]

University of Phoenix

MHA/515: Scanning the Health Sector as an Industry Expert

Week 6 Assignment

[Instructor Name]

[Date]

The health system, its innovation budget, programs and decisions are composites written for a model paper; trial results and research come from the sources cited.

After a year of scanning the environment, validating claims and analyzing trends, the board of a composite three-hospital Tucson system set aside $6 million over two years for innovation and asked the director of strategic planning a final question: which ideas deserve the money? This paper evaluates four candidates and recommends a portfolio.

How the Candidates Were Chosen

The candidates came from the year's work. The environmental scan identified hospital care at home and artificial intelligence. The validation review led to an ambient scribe pilot. The public health assessment identified high blood pressure in 31.9% of Tucson adults and obesity in 34.5%, pointing to innovations in chronic disease care.

A Framework for Judging Innovations

A landmark systematic review of diffusion in service organizations concluded that adoption depends on the innovation's attributes, the adopters, the organization's readiness and the wider system. Among the attributes, innovations spread more readily when they offer a clear relative advantage, are compatible with the organization's values and systems, are not too complex, can be tried on a limited basis, produce observable results and can be adapted locally by the people who use them (Greenhalgh et al., 2004).

The Rating Grid

Each candidate was rated on six dimensions: strength of evidence, relative advantage, compatibility, complexity, trialability and net cost to the system.

Candidate One: Blood Pressure Telemonitoring

In a cluster-randomized trial, patients with uncontrolled hypertension used home blood pressure monitors that transmitted readings to pharmacists, who adjusted medicines. At the 6-month and 12-month checks alike, 57.2% of intervention patients were at goal, against 30.0% in the comparison clinics, and systolic pressure fell 10.7 points more at 6 months; the advantage persisted six months after the program ended (Margolis et al., 2013).

Rating Telemonitoring

Evidence is strong. The advantage is large and clinically meaningful. The program fits the system's primary care clinics and employed pharmacists. Complexity is moderate, requiring device logistics and data flow into the record. It can start in two clinics. Cost is modest, and savings accrue in shared-savings contracts through fewer strokes and heart attacks over time. The innovation with the least glamour had the strongest trial and the easiest path to adoption.

Candidate Two: Obesity Medicines

Weight-loss medicines have changed obesity care. In a trial of 17,604 adults with cardiovascular disease and overweight or obesity but without diabetes, semaglutide reduced major cardiovascular events to 6.5% from 8.0% with placebo over about 40 months, while 16.6% of patients stopped treatment because of adverse events, compared with 8.2% on placebo (Lincoff et al., 2023).

Rating Obesity Medicines

Evidence of clinical benefit is strong. But the medicines are expensive, coverage varies and many patients stop treatment. For the system, the innovation is not the drug but the care model around it: a structured obesity medicine clinic with nutrition, exercise and behavioral support and clear criteria for who benefits most. Cost to the system depends on its role as employer and risk-bearing provider.

Candidate Three: Ambient Scribes

The validation review found real but smaller benefits than vendors claimed, differences between products and occasional inaccuracies, and the 60-physician pilot is under way. Evidence is moderate, the advantage for physician wellbeing may be meaningful, trialability is high and cost is significant at scale.

Candidate Four: Hospital Care at Home

A randomized trial showed lower cost and fewer readmissions for home hospitalization, but federal payment authority has depended on short-term extensions. Complexity is high, requiring logistics, staffing and technology across Tucson's large geography.

Lessons From the Year

The year's work also taught the planning team what to avoid. The vendor brochure showed how easily enthusiasm outruns evidence. The public health assessment showed that national trends can mislead locally. The design review showed that a decision lasting decades needs flexibility. Each lesson shaped the portfolio: evidence first, local fit second and room to change course throughout.

The Portfolio

The director recommended four allocations. Telemonitoring receives $1.8 million to expand from two clinics to all primary care sites over two years. The obesity medicine clinic receives $1.6 million to build a structured program in partnership with the system's employee health plan and two payers. The ambient scribe pilot receives $1.2 million to complete and, if results warrant, expand to 200 physicians. Hospital care at home receives $400,000 for planning and a limited pilot only if payment policy becomes stable. The remaining $1 million is reserved for opportunities that arise during the two years.

Measures for Each

Telemonitoring: blood pressure control rates among enrolled patients. Obesity clinic: weight change, cardiovascular risk factors and treatment persistence. Scribes: time in notes, burnout and note accuracy. Care at home: readiness and policy status.

Decision Points

Each innovation has a decision point at 12 months, where results determine whether to expand, adjust or stop. Ending an innovation that fails to deliver shows the process working as designed.

Who Benefits and Who Pays

The innovations differ in who captures the value. Telemonitoring reduces future strokes and heart attacks, benefits that flow mainly to payers and to the system only through shared-savings contracts. The obesity program's benefits appear years later, often after patients change insurers. Ambient scribes benefit physicians and the system directly through retention. Understanding who benefits shaped the funding plan: the system sought payer partners for the first two and paid for the third itself.

Equity

Innovations can widen gaps if they reach only patients with smartphones, reliable internet or good insurance. Telemonitoring will use cellular-connected cuffs that need no smartphone, and clinics serving the system's lowest-income neighborhoods will start first. The obesity program will set clinical criteria for access rather than limiting it to patients whose plans cover the medicines, and will seek manufacturer assistance and payer agreements for others.

Barriers Staff Raised

Primary care teams worried that telemonitoring would flood them with readings. The design routes readings to pharmacists, who contact physicians only when medicines need changing. Physicians worried that the obesity clinic would create waiting lists; it will begin with patients at highest cardiovascular risk. Listening to staff before launch addressed the barriers the diffusion review identifies as common among adopters.

Implementation Capacity

Innovations compete for the same clinicians, analysts and managers. The system created an innovation office with a small team to support clinics in implementation, including training, workflow redesign and data.

What Ties the Course Together

The portfolio draws on each skill the course developed: scanning found the candidates, validation separated evidence from claims, trend analysis showed where needs were growing and the diffusion framework judged adoptability.

Conclusion

The board asked which innovations deserved $6 million. Judged on evidence and attributes that predict spread, telemonitoring earned the largest share, a structured obesity program the next, the scribe pilot a chance to prove itself and care at home a watchful plan. A portfolio with measures and decision points lets the system learn quickly and spend on what works.

References

Greenhalgh, T., Robert, G., Macfarlane, F., Bate, P., & Kyriakidou, O. (2004). Diffusion of innovations in service organizations: Systematic review and recommendations. The Milbank Quarterly, 82(4), 581-629. https://doi.org/10.1111/j.0887-378X.2004.00325.x

Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., Deanfield, J., Emerson, S. S., Esbjerg, S., Hardt-Lindberg, S., Hovingh, G. K., Kahn, S. E., Kushner, R. F., Lingvay, I., Oral, T. K., Michelsen, M. M., Plutzky, J., Tornøe, C. W., & Ryan, D. H. (2023). Semaglutide and cardiovascular outcomes in obesity without diabetes. New England Journal of Medicine, 389(24), 2221-2232. https://doi.org/10.1056/NEJMoa2307563

Margolis, K. L., Asche, S. E., Bergdall, A. R., Dehmer, S. P., Groen, S. E., Kadrmas, H. M., Kerby, T. J., Klotzle, K. J., Maciosek, M. V., Michels, R. D., O'Connor, P. J., Pritchard, R. A., Sekenski, J. L., Sperl-Hillen, J. M., & Trower, N. K. (2013). Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: A cluster randomized clinical trial. JAMA, 310(1), 46-56. https://doi.org/10.1001/jama.2013.6549